Provided by Tiger Trade Technology Pte. Ltd.

Lineage

34.34
+0.37001.09%
Post-market: 34.20-0.1400-0.41%19:30 EDT
Volume:957.11K
Turnover:33.00M
Market Cap:7.80B
PE:-47.69
High:34.91
Open:34.49
Low:34.15
Close:33.97
52wk High:45.75
52wk Low:31.33
Shares:227.08M
Float Shares:57.19M
Volume Ratio:0.73
T/O Rate:1.67%
Dividend:2.12
Dividend Rate:6.16%
EPS(TTM):-0.7200
EPS(LYR):-0.4300
ROE:-2.04%
ROA:0.75%
PB:0.99
PE(LYR):-79.86

Loading ...

Lineage, Inc. Earnings Call Balances Progress And Risk

TIPRANKS
·
May 07

Lineage Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 06

Lineage Posts Modest Growth and Raises Dividend Outlook

TIPRANKS
·
May 06

Adam Kramer Maintains Hold on Lineage Amid Transitional 2026, Soft Same-Store Trends, and Uncertain Demand Recovery

TIPRANKS
·
May 06

Lineage Q1 Adjusted FFO Falls, Revenue Rises; Reiterates Full-Year AFFO Outlook

MT Newswires Live
·
May 06

GUIDANCE: (LINE) Lineage Expects 2026 Adjusted FFO per Share Range $2.75 to $3.00, vs. FactSet Est of $2.88

MT Newswires Live
·
May 06

Lineage Q1 revenue misses estimates, adjusted EBITDA beats

Reuters
·
May 06

Earnings Flash (LINE) Lineage Posts Q1 AFFO $0.78 a Share, vs. FactSet Est of $0.70

MT Newswires Live
·
May 06

Lineage Q1 EPS $(0.18) Misses $(0.14) Estimate, Sales $1.297B Miss $1.322B Estimate

Benzinga Earnings
·
May 06

Lineage Inc - Sees FY2026 Adj Ebitda $1.25-$1.30 Bln; Affo per Share $2.75-$3.00

THOMSON REUTERS
·
May 06

Lineage Inc: Supply Chain Conditions Remain Challenging Due to Tariff Uncertainty and Geopolitical Disruptions

THOMSON REUTERS
·
May 06

Lineage Inc Q1 Adjusted Ffo per Share USD 0.78

THOMSON REUTERS
·
May 06

Lineage Inc Q1 Pretax Profit USD -47 Million

THOMSON REUTERS
·
May 06

Lineage, Inc. Reports First-Quarter 2026 Financial Results

THOMSON REUTERS
·
May 06

Top News Today: Stocks Rise, Oil Falls, as War Restart Fears Subside

Dow Jones
·
May 06

Lineage Cell Therapeutics Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 04

Lineage Inc expected to post a loss of 6 cents a share - Earnings Preview

Reuters
·
May 04

Earning Preview: Lineage this quarter’s revenue is expected to decrease by 1.25%, and institutional views are leaning bullish

Earnings Agent
·
Apr 29

Lineage Cell Therapeutics Initiated at Buy by Canaccord Genuity

Dow Jones
·
Apr 29

Canaccord Genuity Initiates Coverage on Lineage Cell Therapeutics With Buy Rating, $9 PT

MT Newswires Live
·
Apr 28